Amneal Pharmaceuticals, Inc.
AMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723128
In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Amneal Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 183 | 3 | 200 | +20 |
| Shares | 142.7M | 245.1K | 126.1M | −16.4M (−11.5%) |
| Value | $1.19B | $2.04M | $998.7M | −$186.8M (−15.8%) |
3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (42)
Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (22)
Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Fosun International Ltd | 1,720,855 | $14.3M |
| Polar Asset Management Partners Inc. | 393,000 | $3.27M |
| Jacobs Levy Equity Management, Inc | 97,379 | $810.2K |
| Jane Street Group, LLC | 81,883 | $681.3K |
| Jefferies Financial Group Inc. | 80,000 | $665.6K |
| Versor Investments LP | 40,200 | $334.5K |
| American Century Companies Inc | 32,714 | $272.2K |
| Caxton Associates LP | 29,150 | $242.5K |
| Two Sigma Investments, LP | 27,245 | $226.7K |
| Aigen Investment Management, LP | 25,591 | $212.9K |
| Quadrature Capital Ltd | 20,336 | $169.2K |
| EntryPoint Capital, LLC | 12,725 | $105.9K |
| HighTower Advisors, LLC | 12,192 | $103.0K |
| Two Sigma Securities, LLC | 10,582 | $88.0K |
| Gladius Capital Management LP | 4,390 | $36.5K |
| Optiver Holding B.V. | 1,245 | $10.4K |
| Rise Advisors, LLC | 500 | $4.16K |
| Frazier Financial Advisors, LLC | 490 | $4.08K |
| Capital Performance Advisors LLP | 163 | $1.36K |
| Bessemer Group Inc | 160 | $1.00K |
| National Bank of Canada | 2 | $17 |
| Global Retirement Partners, LLC | 1 | $8 |
Not filed for Q4 2024 yet (3)
Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 161,380 | $1.34M |
| Chartwell Investment Partners, LLC | 82,410 | $686.0K |
| ClariVest Asset Management LLC | 1,317 | $8.36K |